Skip to content

Author

G. Schwartz

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Nov 2026

Abstract 10036: Apolipoproteins and Cardiovascular-Kidney-Metabolic-Biomarkers Each Add to Prediction of Residual Cardiovascular Disease Risk After Acute Coronary Syndrome: Insights from the ODYSSEY OUTCOMES Trial

The conclusion that residual risk in ACS is multidimensional is supported, and comprehensive biomarker profiling with a multiplex apolipoprotein panel including apoE phenotypes and emerging CKM tests each provides clinically meaningful improvement in the prediction of MACE and death beyond conventional demographics, di...

N. V. van Neer, J. Jukema, L. Ruhaak et al. · 0 citations
Review Open access Oct 2026

Design and baseline data of AZURE-HeFH, a phase 3 study assessing the effect of the oral PCSK9 inhibitor laroprovstat on LDL cholesterol in patients with heterozygous familial hypercholesterolaemia

Patients with heterozygous familial hypercholesterolaemia (HeFH), if untreated or undertreated, are characterised by lifelong exposure to elevated low density lipoprotein cholesterol (LDLc) levels, associated with a markedly increased risk of atherosclerotic cardiovascular disease (ASCVD). Recent surveys, however...

E. Stroes, R. S. Rosenson, R. Santos et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.